These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17939761)

  • 21. Promising new therapies for malignant gliomas.
    Fine HA
    Cancer J; 2007; 13(6):349-54. PubMed ID: 18032970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.
    Ren H; Tan X; Dong Y; Giese A; Chou TC; Rainov N; Yang B
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):241-52. PubMed ID: 19159435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo.
    Roth P; Kissel M; Herrmann C; Eisele G; Leban J; Weller M; Schmidt F
    Clin Cancer Res; 2009 Nov; 15(21):6609-18. PubMed ID: 19825946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
    Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
    Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy: a new paradigm for androgen-refractory prostate cancer.
    Loughlin KR
    Urol Oncol; 2008; 26(6):575. PubMed ID: 18996313
    [No Abstract]   [Full Text] [Related]  

  • 26. Resistance in malignant tumors: can resistance assays optimize cytostatic chemotherapy?
    Lippert TH; Ruoff HJ; Volm M
    Pharmacology; 2008; 81(3):196-203. PubMed ID: 18176090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer vaccines: maximizing a suboptimal immune response for improved outcome.
    Slovin SF
    Clin Adv Hematol Oncol; 2007 Dec; 5(12):972-80. PubMed ID: 18277959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The XIAP inhibitor Embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP.
    Siegelin MD; Gaiser T; Siegelin Y
    Neurochem Int; 2009 Nov; 55(6):423-30. PubMed ID: 19409438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current immunotherapeutic strategies in breast cancer.
    Carson WE; Liang MI
    Surg Oncol Clin N Am; 2007 Oct; 16(4):841-60, ix. PubMed ID: 18022548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA repair and resistance of gliomas to chemotherapy and radiotherapy.
    Frosina G
    Mol Cancer Res; 2009 Jul; 7(7):989-99. PubMed ID: 19609002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy is useful in the treatment of gliomas. Discussant.
    Ashley DM
    J Clin Neurosci; 2000 Sep; 7(5):467-8. PubMed ID: 10942679
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical significance of mustoforan in management of malignant glioma].
    Kobiakov GL
    Vopr Onkol; 2007; 53(6):724-9. PubMed ID: 18416147
    [No Abstract]   [Full Text] [Related]  

  • 33. Development trends for new cancer therapeutics and vaccines.
    Reichert JM; Wenger JB
    Drug Discov Today; 2008 Jan; 13(1-2):30-7. PubMed ID: 18190861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-transplant immunotherapy: combining cancer vaccines with hematopoietic stem cell transplantation.
    Holtick U; von Bergwelt-Baildon M
    Expert Rev Vaccines; 2009 May; 8(5):519-23. PubMed ID: 19397408
    [No Abstract]   [Full Text] [Related]  

  • 35. New therapeutic developments in renal cell cancer.
    Prenen H; Gil T; Awada A
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):56-63. PubMed ID: 18752971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent chemoradiotherapy for malignant glioma: dead end or highway?
    Mirimanoff RO
    Onkologie; 2008 Sep; 31(8-9):430-1. PubMed ID: 18787348
    [No Abstract]   [Full Text] [Related]  

  • 37. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.
    Everson RG; Graner MW; Gromeier M; Vredenburgh JJ; Desjardins A; Reardon DA; Friedman HS; Friedman AH; Bigner DD; Sampson JH
    Expert Rev Anticancer Ther; 2008 May; 8(5):717-32. PubMed ID: 18471045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of glioma].
    Takakura K
    Kango Gijutsu; 1978 Feb; 24(3):44-52. PubMed ID: 246062
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuro-oncology: Mice vaccinated against tumour recurrence.
    Malkki H
    Nat Rev Neurol; 2014 Aug; 10(8):428. PubMed ID: 25002106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.